Kocher, F.; Mian, M.; Seeber, A.; Fiegl, M.; Stauder, R.
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent. J. Clin. Med. 2020, 9, 1005.
https://doi.org/10.3390/jcm9041005
AMA Style
Kocher F, Mian M, Seeber A, Fiegl M, Stauder R.
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent. Journal of Clinical Medicine. 2020; 9(4):1005.
https://doi.org/10.3390/jcm9041005
Chicago/Turabian Style
Kocher, Florian, Michael Mian, Andreas Seeber, Michael Fiegl, and Reinhard Stauder.
2020. "The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent" Journal of Clinical Medicine 9, no. 4: 1005.
https://doi.org/10.3390/jcm9041005
APA Style
Kocher, F., Mian, M., Seeber, A., Fiegl, M., & Stauder, R.
(2020). The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent. Journal of Clinical Medicine, 9(4), 1005.
https://doi.org/10.3390/jcm9041005